A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
PDF) Modified mRNA Vaccines Protect against Zika Virus Infection
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Nanomaterials | Free Full-Text | Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives | HTML
Crowd fund launched for 'Battlestar Galactica' actor Michael Hogan after brain injury
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Moderna's coronavirus vaccine shows encouraging early results - The Washington Post
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
Nanotechnology for COVID-19: Therapeutics and Vaccine Research. - Abstract - Europe PMC
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
Moderna Therapeutics — Wikipédia
PDF) mRNA vaccines — a new era in vaccinology
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
